You are here

RSV

GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study

Biopharma Reporter

Tue, 11/24/20 - 10:49 am

clinical trials

GSK sees 'robust immune response' from RSV vaccine hopefuls

Fierce Pharma

Wed, 10/21/20 - 10:38 am

clinical trials

As Moderna doubles down on vaccines, Merck pulls out of a long-running collaboration

Endpoints

Thu, 10/8/20 - 11:03 am

Moderna Therapeutics

Icosavax raises $51M to take VLP RSV vaccine into humans

Fierce Biotech

Thu, 10/3/19 - 10:40 am

viruslike particle

Meissa raises $30M to take RSV vaccine into the clinic

Fierce Biotech

Thu, 09/26/19 - 10:48 am

Meissa Vaccines

clinical trials

Enanta's lung infection therapy succeeds in mid-stage trial

Reuters

Fri, 06/14/19 - 06:28 pm

Enanta Pharmaceuticals

clinical trials

Novavax still plans to push RSV vaccine to market after failed trial

Bizjournals

Tue, 06/11/19 - 09:41 am

clinical trials

J&J mops up $900M in waste, writing off the last big chunk of the $1.75B it spent to acquire Alios

Endpoints

Thu, 03/21/19 - 11:09 pm

Can Novavax Convince the FDA Its Vaccine Deserves a Chance?

Motley Fool

Fri, 03/1/19 - 11:54 pm

clinical trials

Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward

Endpoints

Thu, 02/28/19 - 10:04 am

clinical trials

AZ’s lung drug gets fast development in EU and US

Pharmaforum

Tue, 02/5/19 - 09:49 am

AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis

Endpoints

Tue, 11/13/18 - 10:29 am

J&J takes $630M hit on RSV drug bought with Alios

Fierce Biotech

Thu, 10/18/18 - 11:22 am

Alios BioPharma

ReViral Completes $55 Million Series B Round to Advance RSV Treatment

CP Wire

Wed, 08/1/18 - 10:45 am

Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine

CP Wire

Tue, 05/22/18 - 11:27 am

clinical trials

Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine

Tue, 05/22/18 - 08:30 am

Ph III Study of Infant via Maternal Immunization Vaccine for RSV Reaches Milestone

CP Wire

Mon, 05/7/18 - 05:24 pm

infant via maternal immunization

JPM18: Novavax investors cheer RSV vaccine update, then pull back

Biopharma Dive

Thu, 01/11/18 - 11:49 pm

In a rare misfire, Regeneron scraps its RSV drug after a PhIII failure

Endpoints

Mon, 08/14/17 - 09:36 pm

clinical trials

Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb

Endpoints

Tue, 07/25/17 - 12:02 am

Pages